Jonghyun Bae1,2,3, Ayesha Das3, Isabel Reyes4, Sawwal Qayyum5, Jin Zhang5, Arjun Masurkar4, and Sungheon Gene Kim5
1Vilcek Institute of Graduate Biomedical Science, NYU School of Medicine, New York, NY, United States, 2Center for Advanced Imaging Innovation and Research, Radiology, NYU School of Medicine, New York, NY, United States, 3Radiology, Weill Cornell Medical College, New York, NY, United States, 4Neurology, NYU Langone Health, New York, NY, United States, 5Weill Cornell Medical College, New York, NY, United States
Synopsis
Keywords: Alzheimer's Disease, Aging
Recent studies have suggested that the increase in blood-brain barrier
(BBB) permeability is associated with both aging and the progression of the Alzheimer’s
disease (AD). However, the association of the amyloid pathology with the
increased BBB leakage at different disease progression is still poorly
understood. In this study, we performed a cross-sectional study to investigate
the BBB permeability changes in AD transgenic mice with aging. We also propose
the network-aided analysis allows the scan time reduction without compromising
the accuracy of the detection of the subtle permeability
Purpose
Recent
studies have shown that increased blood-brain barrier (BBB) permeability is
associated with aging (1), as well as the Alzheimer’s
disease (AD) (2). However, these human studies are
limited by challenges in identifying the causes of the vascular changes,
because of the difficulties of conducting longitudinal studies and obtaining
tissue samples. Animal models for the Alzheimer’s disease allow to segregate
the different aspect of disease and its effect in pathological development.
Although several studies identify the physiological changes associated with
aging (3,
4), these imaging studies are conducted on relatively
aged mice, which hinders the understanding of pathological development with
aging. In this study, we conduct a cross-sectional study at a wide range of
ages and investigate how the progression of the amyloid pathology contributes
to the vascular changes along different ages. In addition, we adopt the
previously proposed deep-learning approach(5) to demonstrate the improved
sensitivity in detecting subtle BBB permeability changes with the clinically
relevant scan time.Methods
Animals
Groups of 5xFAD mice (n=6, Female/male (n = 3/3)) and the wild-type littermate
(n=4, Female/male (n = 1/3)) were included in this study. 5xFAD mice express
human Amyloid Precursor Protein (APP) and PSEN1 transgene, which drive an
aggressive amyloid pathology(6). The age for the mice ranged
between 4 to 16 months at the time of scan.
MRI
experiment
The dynamic contrast-enhanced (DCE) MRI study using a 3D UTE pulse sequence with
3D golden angle projections were performed on a Bruker 7T micro-MRI system with
a cryo-coil. (TR=5ms, TE=0.028ms, Flip-angle = 10 deg, Image
Matrix=128x128x128, FOV=17x17x17mm3). The total scan time was 30min,
while a bolus of gadolinium (Gadavist) contrast agent was injected at 2min into
the scan. The acquired dynamic images were reconstructed at 5s temporal
resolution using iterative GRASP reconstruction(7).
Pharmacokinetic
Modelling analysis (PKM)
The PKM analysis was
conducted on a single slice that contains the hippocampal region. The analysis
was conducted on the whole-brain ROI. The arterial input function (AIF) was
sampled using a DCE toolkit known as ROCKETSHIP(8). The capillary-input function (CIF) was
estimated from the vision transformer-based deep learning network, which was
trained on the simulated contrast dynamics from human studies. The CIF network
receives an input of a patch of contrast dynamics, as shown in Figure 1, and
predicts the local input function to that patch, as elucidated in our previous
work(5). The graphical Patlak model (9) was used to assess the BBB permeability. The
analysis was performed using AIF on 30-min data and truncated 10-min data. The
same analysis was repeated on the 10-min data with the network-predicted CIF.
The estimated permeability was compared among AIF-30min data (Ca-30min),
AIF-10min data (Ca-10min) and CIF-10min data (Cp-10min). Result
BBB
permeability with aging
Figure 2 shows example signal dynamics in WT and AD transgenic mice at
different ages. As shown, the 8 month old mice show only subtle difference in
contrast dynamics, while the contrast dynamics in more aged mice show remarkable
difference between WT and AD. Figure 3 shows the estimated permeability with
aging spectrum, which exhibits the increased trend in AD mice associated with
aging, while the WT mice does not show increased permeability.
Improved
sensitivity with CIF network
Figure 4 shows the estimated permeability maps from the 30-min data, 10-min
data using AIF and 10-min data using CIF. When the scan time is reduced, the
conventional approach with AIF results in overestimation of the permeability.
However, when the local CIF is used, the overestimation is substantially
reduced. Figure 5 shows the whisker-box plot for each measure for AD and WT
mice along the age spectrum. With the scan time reduction, the estimates using
CIF demonstrates better accuracy and precision as compared to the estimates
using AIF.Discussion & Conclusion
The
preliminary result from our study demonstrates increased BBB permeability in AD
transgenic mouse after 15 months, while the WT mouse does not exhibit vascular
changes that are detectable with DCE-MRI study. In addition, our analysis
suggests that when the scan time is reduced, the conventional approach may
over-estimate the permeability estimates, as suggested by the previous study (10). However, the network-predicted
CIF allows the scan-time reduction without compromising the accuracy of the
subtle permeability estimates. Our future work aims to include more mice at
different ages to investigate the longitudinal changes across a broader age spectrum.Acknowledgements
R01CA160620References
1. Montagne
A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood-brain
barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296-302.
2. Backes WH, van Buchem MA. Blood-Brain
Barrier Leakage in Patients with Early Alzheimer Disease. Radiology.
2016;281:527-35.
3. Minogue AM, Jones RS, Kelly RJ,
McDonald CL, Connor TJ, Lynch MA. Age-associated dysregulation of microglial
activation is coupled with enhanced blood-brain barrier permeability and
pathology in APP/PS1 mice. Neurobiology of aging. 2014;35(6):1442-52.
4. Blockx I, Einstein S, Guns P-J, Van
Audekerke J, Guglielmetti C, Zago W, et al. Monitoring blood-brain barrier
integrity following amyloid-β immunotherapy using gadolinium-enhanced MRI in a
PDAPP mouse model. Journal of Alzheimer's Disease. 2016;54(2):723-35.
5. Bae J, Huang Z, Knoll F, Geras K,
Pandit Sood T, Feng L, et al. Estimation of the capillary level input function
for dynamic contrast‐enhanced MRI of the breast using a deep learning approach.
Magnetic Resonance in Medicine. 2022;87(5):2536-50.
6. Devi L, Ohno M. Genetic reductions
of β‐site amyloid precursor protein‐cleaving enzyme 1 and amyloid‐β ameliorate
impairment of conditioned taste aversion memory in 5XFAD Alzheimer’s disease
model mice. European Journal of Neuroscience. 2010;31(1):110-8.
7. Feng L, Grimm R, Block KT,
Chandarana H, Kim S, Xu J, et al. Golden‐angle radial sparse parallel MRI:
combination of compressed sensing, parallel imaging, and golden‐angle radial
sampling for fast and flexible dynamic volumetric MRI. Magnetic resonance in
medicine. 2014;72(3):707-17.
8. Barnes SR, Ng TS, Santa-Maria N,
Montagne A, Zlokovic BV, Jacobs RE. ROCKETSHIP: a flexible and modular software
tool for the planning, processing and analysis of dynamic MRI studies. BMC
medical imaging. 2015;15(1):1-20.
9. Patlak CS, Blasberg RG,
Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants
from multiple-time uptake data. Journal of Cerebral Blood Flow &
Metabolism. 1983;3(1):1-7.
10. Bae
J, Zhang J, Wadghiri YZ, Minhas AS, Poptani H, Ge Y, et al. Measurement of
blood‐brain barrier permeability using dynamic contrast‐enhanced magnetic
resonance imaging with reduced scan time. Magnetic resonance in medicine.
2018;80(4):1686-96.